A randomized controlled trial of moral reconation therapy to reduce risk for criminal recidivism among justice-involved adults in mental health residential treatment.
Journal
Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
pubmed:
12
4
2022
medline:
26
5
2022
entrez:
11
4
2022
Statut:
ppublish
Résumé
Moral reconation therapy (MRT) is a cognitive-behavioral intervention to reduce risk for criminal recidivism. Despite being implemented widely in correctional settings, there are no randomized controlled trials of MRT, and its effectiveness for reducing recidivism among justice-involved adults in noncorrectional settings is unknown. In a pragmatic trial, 341 justice-involved patients (95.3% male; 57.8% White/non-Hispanic) admitted to one of three mental health residential treatment programs were randomly assigned to usual care (UC) or UC plus two MRT groups per week for 12 weeks. Follow-ups were conducted at 6- and 12-month postbaseline (71.3% and 74.8% retention, respectively). Primary outcomes were criminal thinking and criminal associates. Secondary outcomes were legal problem severity, days incarcerated in the past 30, rearrested/charged (per official records), substance use, and employment and family/social problems. The study design, analysis, and outcomes were preregistered (ClinicalTrials.gov; ID: NCT02524171). Patients in both conditions improved over time on most outcomes. In intent-to-treat analyses, the rate of change in outcomes over time did not differ by condition, nor did the prevalence of being rearrested and charged within 1 year of baseline (UC = 20.2%, MRT = 24.9%; In this study, MRT was not more effective than UC at reducing recidivism risk for patients in mental health residential treatment. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Identifiants
pubmed: 35404638
pii: 2022-51846-001
doi: 10.1037/ccp0000721
pmc: PMC9426716
mid: NIHMS1830811
doi:
Banques de données
ClinicalTrials.gov
['NCT02524171']
Types de publication
Journal Article
Pragmatic Clinical Trial
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
413-426Subventions
Organisme : HSRD VA
ID : I01 HX001570
Pays : United States
Références
J Trauma Stress. 2020 Oct;33(5):804-812
pubmed: 32516492
Psychiatr Serv. 2009 Feb;60(2):224-30
pubmed: 19176417
J Nerv Ment Dis. 2003 Mar;191(3):145-53
pubmed: 12637840
Int J Offender Ther Comp Criminol. 2013 Sep;57(9):1076-106
pubmed: 22744908
Drug Alcohol Depend. 2020 Dec 1;217:108396
pubmed: 33234300
Psychol Serv. 2013 Feb;10(1):54-65
pubmed: 23148768
Int J Offender Ther Comp Criminol. 2018 Sep;62(12):3746-3774
pubmed: 29303015
Psychiatr Serv. 2013 Sep 1;64(9):843-9
pubmed: 23728358
Lancet Psychiatry. 2021 Sep;8(9):759-773
pubmed: 34419185
Int J Offender Ther Comp Criminol. 2018 Oct;62(13):4278-4294
pubmed: 29478392
Arch Gen Psychiatry. 2006 Apr;63(4):426-32
pubmed: 16585472
Subst Abuse. 2020 Feb 24;14:1178221819901281
pubmed: 32132821
Am J Addict. 2006 Mar-Apr;15(2):113-24
pubmed: 16595348
BMC Health Serv Res. 2018 Mar 7;18(1):164
pubmed: 29514649
BMJ. 2012 Jul 24;345:e4692
pubmed: 22833604
Front Psychiatry. 2019 Apr 12;10:219
pubmed: 31031658
Psychol Rep. 1991 Dec;69(3 Pt 2):1151-4
pubmed: 1792284
J Stud Alcohol Drugs. 2017 May;78(3):463-467
pubmed: 28499115
Drug Alcohol Depend. 1996 Sep;42(1):49-54
pubmed: 8889403
J Community Health. 2006 Apr;31(2):123-35
pubmed: 16737173
Adm Policy Ment Health. 2021 Nov;48(6):992-1005
pubmed: 33515346
Psychol Assess. 2016 Jun;28(6):652-9
pubmed: 26237208
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Assessment. 2002 Sep;9(3):240-53
pubmed: 12216781
Psychiatr Serv. 2022 Aug 1;73(8):856-863
pubmed: 35080418
Law Hum Behav. 2016 Aug;40(4):411-9
pubmed: 26974366
Psychol Rep. 1988 Feb;62(1):135-51
pubmed: 3283816